1. Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus

   • Pau Montesinos
   • Juan Bergua
   • Miguel Ángel Sanz

   Review Article 30 October 2019 Pages: 2467 - 2483

   

2. Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis

   • Xia Wu
   • Huifang Wang
   • Yuping Gong

   Review Article 03 September 2019 Pages: 2485 - 2496

   

3. A CARD9 single-nucleotide polymorphism rs4077515 is associated with reduced susceptibility to and severity of primary immune thrombocytopenia

   • Zi Sheng
   • Ju Li
   • Qi Feng

   Original Article 08 October 2019 Pages: 2497 - 2506

4. Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients

   • Oladele Simeon Olatunya
   • Carolina Lanaro
   • Fernando Ferreira Costa

   Original Article 06 September 2019 Pages: 2507 - 2521

   

5. Hypomethylating agents for patients with myelodysplastic syndromes prior to hematopoietic stem cell transplantation: a systematic review and meta-analysis

   • Yao Qin
   • Pu Kuang
   • Ting Liu

   Original Article 22 October 2019 Pages: 2523 - 2531

   

6. Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data

   • Shreekant Parasuraman
   • Jingbo Yu
   • Robyn Scherber

   Original Article Open access 24 September 2019 Pages: 2533 - 2539

   

7. Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma

   • Jun Ho Yi
   • Gyeong-Won Lee
   • Won Seog Kim

   Original Article 06 September 2019 Pages: 2541 - 2550

   

8. The prognostic significance of Wilms’ tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia

   • Ya-Zhen Qin
   • Qian Jiang
   • Xiao-Jun Huang

   Original Article 06 September 2019 Pages: 2551 - 2559

   

9. Evaluation of cerebrospinal clonal gene rearrangement in newly diagnosed non-Hodgkin’s lymphoma patients

   • Boaz Nachmias
   • Veronica Sandler
   • Moshe E. Gatt

   Original Article 12 September 2019 Pages: 2561 - 2567

   

10. Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia

    • Ella Willenbacher
    • Karin Jöhrer
    • Brigitte Kircher

    Original Article Open access 18 October 2019 Pages: 2569 - 2578

    

11. Comparison of calcineurin inhibitors in combination with conventional methotrexate, reduced methotrexate, or mycophenolate mofetil for prophylaxis of graft-versus-host disease after umbilical cord blood transplantation

    • Shuro Yoshida
    • Yuju Ohno
    • Toshihiro Miyamoto

    Original Article 18 October 2019 Pages: 2579 - 2591

    

12. Efficacy and safety of micafungin in unrelated cord blood transplant recipients

    • Takeo Yasu
    • Takaaki Konuma
    • Arinobu Tojo

    Original Article 07 September 2019 Pages: 2593 - 2600

13. Proportion of anemia attributable to iron deficiency in high-altitude infant populations

    • B. Maritza Choque-Quispe
    • Valeria Paz
    • Gustavo F. Gonzales

    Letter to the Editor 30 October 2019 Pages: 2601 - 2603

    

14. Characteristics and course of patients with advanced hematologic malignancies receiving specialized inpatient palliative care at a German university hospital

    • Dennis A. Eichenauer
    • Heidrun Golla
    • Klaus Maria Perrar

    Letter to the Editor 28 June 2019 Pages: 2605 - 2607

15. Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy

    • Mario Tiribelli
    • Elisabetta Abruzzese
    • Renato Fanin

    Letter to the Editor 16 September 2019 Pages: 2609 - 2611

16. Epstein–Barr virus–associated post-transplant lymphoproliferative disorder among long-term survivors of adults after single cord blood transplantation without antithymocyte globulin

    • Masamichi Isobe
    • Takaaki Konuma
    • Arinobu Tojo

    Letter to the Editor 29 October 2019 Pages: 2613 - 2615

17. Primary intraocular natural killer-cell lymphoma successfully treated using a multidisciplinary strategy

    • Tomoko Takimoto-Shimomura
    • Yuji Shimura
    • Junya Kuroda

    Letter to the Editor 21 October 2019 Pages: 2617 - 2619

    

18. ASXL2 mutation is recurrent in non-de novo AML1-ETO-negative acute myeloid leukemia

    • Xiang Zhang
    • Jie Jin
    • Wenjuan Yu

    Letter to the Editor 21 October 2019 Pages: 2621 - 2623

    

19. Reversal of skin changes in smoldering myeloma with clinical presentation of POEMS syndrome with a lenalidomide-based regimen

    • Elena E Solomou
    • Panayiotis Marnellos
    • Argiris Symeonidis

    Letter to the Editor 25 October 2019 Pages: 2625 - 2626

    

20. Fatal type B lactic acidosis in a patient with end-stage liver disease related to homozygous sickle cell disease

    • Véronique Masy
    • Etienne Sokal
    • Philippe Hantson

    Letter to the Editor 24 October 2019 Pages: 2627 - 2628